Cargando…
WY14643 Increases Herpesvirus Replication and Inhibits IFNβ Production Independently of PPARα Expression
Peroxisome proliferator activated receptor (PPAR) agonists are commonly used to treat metabolic disorders in humans because they regulate fatty acid oxidation and cholesterol metabolism. In addition to their roles in controlling metabolism, PPAR agonists also regulate inflammation and are immunosupp...
Autores principales: | Tao, Lili, Dryden, Phillip, Lowe, Alexandria, Wang, Guoxun, Achuthkumar, Amritha, Chang, Tyron, Reese, Tiffany A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100363/ https://www.ncbi.nlm.nih.gov/pubmed/36715509 http://dx.doi.org/10.1128/spectrum.02337-22 |
Ejemplares similares
-
Characterization of WY 14,643 and its Complex with Aldose Reductase
por: Sawaya, Michael R., et al.
Publicado: (2016) -
PPARα Agonist WY-14643 Induces SIRT1 Activity in Rat Fatty Liver Ischemia-Reperfusion Injury
por: Pantazi, Eirini, et al.
Publicado: (2015) -
Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
por: Lake, B G, et al.
Publicado: (1993) -
PPARα Agonist WY-14643 Relieves Neuropathic Pain through SIRT1-Mediated Deacetylation of NF-κB
por: Wen, Wanshun, et al.
Publicado: (2020) -
Chondroprotection of PPARα activation by WY14643 via autophagy involving Akt and ERK in LPS‐treated mouse chondrocytes and osteoarthritis model
por: Zhou, Yang, et al.
Publicado: (2019)